May 1, 2024Research and Practice in Thrombosis and HaemostasisOpen Access

Salvianolic Acid B Inhibits Thrombosis and Directly Blocks the Thrombin Catalytic Site

View Full Paper

Ask AI

Bookmark

Authors

MNMiguel A. D. NevesUniversidade do Porto TNTiffany NiUniversity of Toronto DMDaniel Thomas MacKeiganSt. Michael's Hospital

Discussion

Member takes

Implication

Laboratory evaluation demonstrates inhibition of thrombosis via direct blockade of the thrombin catalytic site by salvianolic acid B, suggesting potential anticoagulant utility.

Key Points

Salvianolic acid B inhibits pathological thrombosis by acting as an inhibitor that directly targets and blocks the enzymatic thrombin catalytic site during coagulation cascades.
Direct molecular blockade of the thrombin catalytic site prevents target enzymatic activity, providing mechanistic evidence for the antithrombotic actions of salvianolic acid B.
Targeted inhibition of thrombin provides a mechanistic basis for developing salvianolic acid B as an antithrombotic agent, though additional in vivo validation remains warranted.

Cite This Study

Neves et al. (2024) studied this question.

synapsesocial.com/papers/68e6c03bb6db64358763fa3f https://doi.org/10.1016/j.rpth.2024.102443

View Full Paper

Ask AI

Bookmark

Implication

Laboratory evaluation demonstrates inhibition of thrombosis via direct blockade of the thrombin catalytic site by salvianolic acid B, suggesting potential anticoagulant utility.

Salvianolic Acid B Inhibits Thrombosis and Directly Blocks the Thrombin Catalytic Site

Discussion

Member takes

Implication

Key Points

Cite This Study

Salvianolic Acid B Inhibits Thrombosis and Directly Blocks the Thrombin Catalytic Site

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider